
How Many COVID Vaccine Boosters Will We Need?
Endless boosting might not be a practical or sustainable strategy, scientists say

How Many COVID Vaccine Boosters Will We Need?
Endless boosting might not be a practical or sustainable strategy, scientists say

COVID Quickly, Episode 22: Colds Build COVID Immunity and the Omicron Vaccine Delay
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between.
You can listen to all past episodes here.


What’s Holding Up New Omicron Vaccines?
Vaccine makers worry yet another variant will start dominating in the months it takes to roll out shots against this one

A COVID Vaccine for All
With proved technology and no-frills tech transfer, CORBEVAX is poised to reach hundreds of millions in the coming weeks

COVID Quickly, Episode 21: Vaccines against Omicron and Pandemic Progress
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between.
You can listen to all past episodes here.

The Risk of Vaccinated COVID Transmission Is Not Low
After my son got sick, I dived into the data, and it turns out vaccinated people can and do spread COVID

Omicron Is Likely to Weaken COVID Vaccine Protection—but Boosters Could Restore It
The rapid spread of new variants such as Omicron offers clues to how SARS-CoV-2 is adapting and how the pandemic will play out over the next several months

Boosters Can Help End the COVID Pandemic
The extra shot doesn’t mean that vaccines are ineffective; our bodies just need a reminder

How Scientists Can Update COVID Vaccines against Omicron
A microbiologist explains how Pfizer and Moderna would rapidly adjust mRNA vaccines

COVID Quickly, Episode 20: The Omicron Scare, and Anti-COVID Pills Are Coming
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between.
You can listen to all past episodes here.

The Benefits of Vaccinating Kids against COVID Far Outweigh the Risks of Myocarditis
Vaccination is likely to prevent many more COVID cases than it is to cause a rare and nonfatal heart side effect in five- to 11-year-olds

Omicron Is Here: A Lack of COVID Vaccines Is Partly Why
Global players need to get more vaccines to African nations and convince more people to take them